SCHEMBL668274

SCHEMBL668274

NOC(=O)C1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL668240 0.94
Hydrochloric Acid SCHEMBL27128353 0.92 CES2 (0.43)
SCHEMBL27943933 0.92 CES2 (0.50)
SCHEMBL27383124 0.92 CES2 (0.50)
SCHEMBL668534 0.92 CES2 (0.50)
Hydrochloric Acid SCHEMBL12099257 0.90 CES2 (0.48)
SCHEMBL27944970 0.90 CES2 (0.48)
Hydrochloric Acid SCHEMBL28392169 0.90 CES2 (0.48)
SCHEMBL27925808 0.90 CES2 (0.48)
SCHEMBL24684871 0.88 KMT2A (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174715-A1 PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS INDI MOLECULAR, INC. 2024-05-30 US claimed
US-11919972-B2 Peptide libraries with non-canonical amino acids REGENERON PHARMACEUTICALS, INC. (US) 2024-03-05 US claimed
CN-107739409-A Albumen, protein conjugate and its application for treating diabetes 爱德迪安(北京)生物技术有限公司 2018-02-27 CN claimed
US-9018348-B2 eIF4E binding peptides AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-04-28 US claimed
CN-104302772-A Protein for diabetes treatment, protein conjugate and application thereof ADDA BIOTECH INC 2015-01-21 CN claimed
US-20130130989-A1 EIF4E BINDING PEPTIDES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2013-05-23 US claimed
EP-2569327-A1 EIF4E BINDING PEPTIDES Agency For Science, Technology And Research (SG) 2013-03-20 EP claimed
WO-2011136744-A1 EIF4E BINDING PEPTIDES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2011-11-03 WO claimed
US-20240174715-A1 PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS INDI MOLECULAR, INC. 2024-05-30 US disclosed
CN-111315734-B Substituted 2-azabicyclo [3.1.1] heptane and 2-azabicyclo [3.2.1] octane derivatives as orexin receptor antagonists 克罗诺斯治疗有限公司 2024-03-08 CN disclosed
US-11919972-B2 Peptide libraries with non-canonical amino acids REGENERON PHARMACEUTICALS, INC. (US) 2024-03-05 US disclosed
CN-114621222-A 6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors 诺华股份有限公司 2022-06-14 CN disclosed
CN-114269367-A Therapeutic peptides 科巴公司 2022-04-01 CN disclosed
CN-113518784-A Therapeutic peptides 科巴公司 2021-10-19 CN disclosed
CN-1279395-C Liquid crystal aligning agent, liquid crystal cell using the same, and method for aligning liquid crystal NISSAN CHEMICAL IND LTD (JP) 2006-10-11 CN disclosed
CN-1768069-A Novel carbamoyl and thiocarbamoyl phosphates and pharmaceutical compositions containing them YISSUM RES DEV CO (IL) 2006-05-03 CN disclosed
CN-1323316-A Hepatitis C tripeptide inhibitors BOEHRINGER INGELHEIM CA LTD (CA) 2001-11-21 CN disclosed
CN-1319198-A Liquid crystal aligning agent, liquid crystal cell using the same, and method for aligning liquid crystal NISSAN CHEMICAL IND LTD (JP) 2001-10-24 CN disclosed
CN-1312817-A Dolastatin 15 derivatives BASF AG (DE) 2001-09-12 CN disclosed
EP-0266170-A2 Peptide derivative and its production Takeda Chemical Industries, Ltd. (JP) 1988-05-04 EP disclosed